Rx Propellant Unveils $100 Million Plan for Integrated Life Sciences Facility in Hyderabad. Feb 18, 26
Rx Propellant, a science and R&D infrastructure platform established by Actis and part of General Atlantic, will invest $100 million ... Full Story
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2026